Anti-arrhythmic effects of lidocaine metabolites.

[1]  J. Strong,et al.  The convulsant potency of lidocaine and its N-dealkylated metabolites. , 1973, The Journal of pharmacology and experimental therapeutics.

[2]  A. Atkinson,et al.  Identification of glycinexylidide in patients treated with intravenous lidocaine , 1973, Clinical pharmacology and therapeutics.

[3]  A. Atkinson,et al.  Simultaneous measurement of plasma concentratons of lidocaine and its deethylated metabolite by mass fragmentography , 1972 .

[4]  M. Peach,et al.  The influence of acidosis on the chronotropic effects of tyramine in guinea-pig atria: relation to tyramine uptake and metabolism. , 1972, The Journal of pharmacology and experimental therapeutics.

[5]  C. Difazio,et al.  Lidocaine Metabolism in Normal and Phenobarbital-pretreated Dogs , 1972, Anesthesiology.

[6]  E. Smith,et al.  Antiarrhythmic effects in dogs of lidocaine administered orally and intravenously. , 1972, American heart journal.

[7]  E. Smith,et al.  The acute antiarrhythmic and toxic effects in mice and dogs of 2-ethylamino-2',6-'acetoxylidine (L-86), a metabolite of lidocaine. , 1971, The Journal of pharmacology and experimental therapeutics.

[8]  D C Harrison,et al.  Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. , 1967, The New England journal of medicine.

[9]  A. Beckett,et al.  The metabolism and excretion of lignocaine in man , 1966 .

[10]  J. B. Farmer.  Liberation of noradrenaline from the dog spleen , 1966, The Journal of pharmacy and pharmacology.